ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Blood Cancer Discovery
Latest Publications
TOTAL DOCUMENTS
111
(FIVE YEARS 111)
H-INDEX
2
(FIVE YEARS 2)
Published By American Association For Cancer Research (AACR)
2643-3230, 2643-3249
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0222
◽
2022
◽
pp. bloodcandisc.0222.2021
Author(s):
Tanaya Shree
◽
Vishnu Shankar
◽
Julian JK Lohmeyer
◽
Debra K. Czerwinski
◽
Joseph G Schroers-Martin
◽
...
Keyword(s):
Targeted Therapy
◽
Antibody Response
◽
De Novo
Download Full-text
In This Issue
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-3-1-iti
◽
2022
◽
Vol 3
(1)
◽
pp. 1-1
Download Full-text
Acknowledgment to Reviewers
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-3-1-ar
◽
2022
◽
Vol 3
(1)
◽
pp. 83-83
Download Full-text
Correction: Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0176
◽
2022
◽
Vol 3
(1)
◽
pp. 82-82
Keyword(s):
T Cell
◽
Bispecific Antibody
◽
Tumor Burden
◽
T Cell Exhaustion
◽
Cytotoxic Therapy
◽
Cell Exhaustion
Download Full-text
BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0115
◽
2021
◽
pp. bloodcandisc.0115.2021
Author(s):
Eva J Schaefer
◽
Helen C Wang
◽
Hannah Q Karp
◽
Clifford A Meyer
◽
Paloma Cejas
◽
...
Keyword(s):
Target Genes
◽
Epigenetic Reprogramming
◽
Oncogenic Signaling
Download Full-text
Blockade or deletion of IFNg reduces macrophage activation without compromising CAR-T function in hematologic malignancies
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0181
◽
2021
◽
pp. bloodcandisc.BCD-21-0181-E.2021
Author(s):
Stefanie R Bailey
◽
Sonika Vatsa
◽
Rebecca C Larson
◽
Amanda A Bouffard
◽
Irene Scarfo
◽
...
Keyword(s):
Macrophage Activation
◽
Hematologic Malignancies
◽
Car T
Download Full-text
Potential role of Interferon-y inhibition in refractory cytokine release syndrome associated with CAR T-cell therapy
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0203
◽
2021
◽
pp. bloodcandisc.0203.2021
Author(s):
Kevin O McNerney
◽
Amanda M DiNofia
◽
David T. Teachey
◽
Stephan A Grupp
◽
Shannon L Maude
Keyword(s):
T Cell
◽
Cell Therapy
◽
Potential Role
◽
Cytokine Release
◽
Cytokine Release Syndrome
◽
T Cell Therapy
◽
Car T Cell
◽
Car T Cell Therapy
◽
Car T
Download Full-text
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0095
◽
2021
◽
Author(s):
Michael A. Pulsipher
◽
Xia Han
◽
Shannon L. Maude
◽
Theodore W. Laetsch
◽
Muna Qayed
◽
...
Keyword(s):
Young Adults
◽
Next Generation Sequencing
◽
Acute Lymphoblastic Leukemia
◽
Minimal Residual Disease
◽
Residual Disease
◽
Lymphoblastic Leukemia
◽
Next Generation
◽
Children And Young Adults
◽
Generation Sequencing
◽
Minimal Residual
Download Full-text
Rare sequences make sense of CAR T outcomes
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0199
◽
2021
◽
pp. bloodcandisc.0199.2021
Author(s):
Sara Ghorashian
◽
Jack Bartram
Keyword(s):
Car T
Download Full-text
Splicing-Mediated Antigen Escape from Immunotherapy for B-cell Malignancies
Blood Cancer Discovery
◽
10.1158/2643-3230.bcd-21-0200
◽
2021
◽
Author(s):
Jessie Bourcier
◽
Omar Abdel-Wahab
Keyword(s):
B Cell
◽
B Cell Malignancies
Download Full-text
Load More ...
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close